SPINAL-CORD DYSMYELINATION INDUCED IN-VIVO BY IGM ANTIBODIES TO 3 DIFFERENT MYELIN GLYCOLIPIDS

Citation
J. Rosenbluth et al., SPINAL-CORD DYSMYELINATION INDUCED IN-VIVO BY IGM ANTIBODIES TO 3 DIFFERENT MYELIN GLYCOLIPIDS, Glia, 19(1), 1997, pp. 58-66
Citations number
31
Categorie Soggetti
Neurosciences
Journal title
GliaACNP
ISSN journal
08941491
Volume
19
Issue
1
Year of publication
1997
Pages
58 - 66
Database
ISI
SICI code
0894-1491(1997)19:1<58:SDIIBI>2.0.ZU;2-S
Abstract
It was shown previously (Rosenbluth et al.: J. Neurosci. 16:2635-2641, 1996) that implantation of hybridoma cells that produce an IgM antiga lactocerebroside into the spinal cord of young rats results in the dev elopment of myelin sheaths with a repeat period similar to 2-3x normal , similar to the abnormal peripheral myelin sheaths seen in human IgM gammopathies. We now present evidence that this effect can be reproduc ed in the spinal cord by implanting either of two other hybridomas, O4 and A2B5, that secrete, respectively, antisulfatide and antigangliosi de IgM antibodies. The formation of expanded CNS myelin thus does not depend on antibodies to galactocerebroside specifically but can be med iated by IgM antibodies that react with other myelin glycolipids as we ll. (C) 1997 Wiley-Liss, Inc.